CMS Releases Proposed 2026 Payment Policy Updates for MA and Part D Programs

The Centers for Medicare and Medicaid Services released the 2026 Advance Notice for the Medicare Advantage and the Medicare Part D Prescription Drug Programs that would update payment policies for these programs.
HHS Announces 15 Additional Drugs for Price Negotiations

The Centers for Medicare and Medicaid Services (CMS) has announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations.
Grant Allows UCLA to Launch Autoimmunity Center to Find Cures

The National Institutes of Health has awarded a $3.4 million grant to help establish a new Autoimmunity Center of Excellence at the University of California, Los Angeles.
Grant Awarded to Accelerate Pandemic Influenza mRNA Vaccine Development

The U.S. Department of Health andHuman Services will provide approximately $590 million to Moderna to accelerate the development of mRNAbased pandemic influenza vaccines and enhance mRNA platform capabilities
Multi-Million Dollar Grant Awarded for Organ Transplantation Research

Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million dollar grant from the NIH to advance research in organ transplantation and antibody mediated rejection.
Guidance for Second Medicare Drug Price Negotiation Released

The U.S. Department of Health and Human Services, through the Centers for Medicare and Medicaid Services, has released final guidance outlining the process for the second cycle of negotiations under the Medicare Drug Price Negotiation Program.
CMS Issues Final Rule on 2025 Home Health Prospective Payment Systems

The Centers for Medicare and Medicaid Services issued a final rule on its 2025 home health prospective payment system, which updates Medicare payment policies and rates for home health agencies.
HHS Proposes Rule to Advance Health Equity

A rule has been proposed by the U.S. Department of Health and Human Services to advance health equity and support whole-person care.
HHS Announces Price Cuts for 10 Medicare Drugs

The U.S. Department of Health and Human Services (HHS) has negotiated lower prices for 10 of the most expensive and widely used drugs covered under Medicare, which is expected to save the Medicare program $6 billion in the first year and reduce out-of-pocket costs for beneficiaries by $1.5 billion.
CMS Proposes Payment Cut for Physicians

CMS issued a proposed rule that announces and solicits public comments on proposed policy changes for Medicare payments on or after Jan. 1, 2025.